• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $HNGR

    Hanger Inc.

    Subscribe to $HNGR
    $HNGR
    Medical Specialities
    Health Care

    Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2020, the company operated approximately 704 patient care clinics, and 112 satellite locations in 46 states and the District of Columbia. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.

    IPO Year: 2018

    Exchange: NYSE

    Website: hanger.com

    Recent Analyst Ratings for Hanger Inc.

    DatePrice TargetRatingAnalyst
    7/25/2022$24.00 → $18.75Buy → Hold
    Jefferies
    See more ratings

    Hanger Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hanger, Inc. Completes Acquisition by Patient Square Capital

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on July 21, 2022, and Hanger's stockholders approved the transaction at a Special Meeting of Stockholders held on September 30, 2022. As a result of the completion of the acquisition, Hanger stockholders will receive $18.75 in cash per share of common stock, and Hanger's common stock will no longer be traded on the New York Stock Exchange (NYSE). Wit

      10/3/22 12:30:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger, Inc. Stockholders Approve Acquisition by Patient Square Capital

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm. Vinit Asar, Hanger's President and Chief Executive Officer said, "I would like to express my gratitude to the Hanger stockholders for their support today, and throughout this transaction process. The Hanger team is excited about this partnership with Patient Square Capital, and beginning our next chapter as a private company. We believe this collaboration will enable us to accelerate our growth and enhance our

      9/30/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Frontier Communications Set to Join S&P MidCap 400; Hain Celestial Group to Join S&P SmallCap 600

      NEW YORK, Sept. 27, 2022 /PRNewswire/ -- Frontier Communications Parent Inc. (NASD: FYBR) will replace The Hain Celestial Group Inc. (NASD:HAIN) in the S&P Midcap 400 and The Hain Celestial Group will replace Hanger Inc. (NYSE:HNGR) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 3. Patient Square Capital, LP. is acquiring Hanger in a deal expected to be completed soon pending final closing conditions. The Hain Celestial Group is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Se

      9/27/22 6:16:00 PM ET
      $FYBR
      $HAIN
      $HNGR
      $SPGI
      Telecommunications Equipment
      Telecommunications
      Packaged Foods
      Consumer Staples
    • Hanger Reports Second Quarter 2022 Financial Results

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022. Financial Highlights Net revenues were $312.0 million for the three months ended June 30, 2022, compared to $280.8 million for the same period in 2021, reflecting growth of 11.1 percent. Patient Care same clinic revenue growth per day was 6.2 percent during the period. Net income was $10.1 million for the three months ended June 30, 2022, compared to $10.2 million for the same period in 2021. Income from operations was $20.8 million for the quarter compared to $20.1 million for

      8/8/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Lifshitz Law PLLC Announces Investigations of SBTX, HNGR, PBFX, and IRBT

      NEW YORK, NY / ACCESSWIRE / August 6, 2022 /Silverback Therapeutics, Inc. (NASDAQ:SBTX)Lifshitz Law PLLC announces an investigation into possible breaches of fiduciary duty in connection with SBTX's merger with ARS Pharmaceuticals, Inc. Under Under the terms of the merger agreement, assuming that Silverback's net cash at closing is $240 million, SBTX's equity holders are expected to own approximately 37% of the combined company.If you are an SBTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or email at [email protected], Inc. (NYSE:HNGR)Lifshitz Law

      8/6/22 7:45:00 PM ET
      $HNGR
      $IRBT
      $PBFX
      $SBTX
      Medical Specialities
      Health Care
      Consumer Electronics/Appliances
      Consumer Discretionary
    • Hanger, Inc. Announces Definitive Agreement to be Acquired by Patient Square Capital for $18.75 Per Share in Cash

      Total Enterprise Value of Approximately $1.25 Billion Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction,

      7/21/22 4:13:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Announces Date of 2022 Second Quarter Earnings Release and Conference Call

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022. Hanger's management team will host a conference call to discuss the second quarter 2022 financial results the following morning on Tuesday, August 9, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 020458. A live webcast, replay of the call and earnings release, will be availa

      7/7/22 8:00:00 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger to Present at the Jefferies 2022 Healthcare Conference

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that members of its management team will participate in presentations and meetings at the Jefferies Healthcare Conference taking place June 8-10, 2022. Members of Hanger management will participate in a presentation scheduled for Thursday, June 9, beginning at 10:30 a.m. Eastern time. The conference presentation and replay of the webcast will be available on the investor relations section of the Company's website at investor.hanger.com. About Hanger, Inc. – Headquartered in Austin, Texas, Hanger, Inc. (NYSE:HNGR) provides comprehensive, outcomes-based orthotic

      5/25/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Reports First Quarter 2022 Financial Results

      Company Reports Strong Same Clinic Revenue Growth Trends; Reaffirms Guidance Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the first quarter ended March 31, 2022. Financial Highlights Net revenues were $261.3 million for the three months ended March 31, 2022, compared to $237.5 million for the same period in 2021, reflecting growth of 10.0 percent. Patient Care same clinic revenue growth per day was 6.9 percent during the period with continuing increases in work-in-process levels during the quarter. Net loss was $8.0 million for the three months ended March 31, 2022, compare

      5/4/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Announces Date of 2022 First Quarter Earnings Release and Conference Call

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the first quarter and three months ended March 31, 2022 after the stock market closes on Wednesday, May 4, 2022. Hanger's management team will host a conference call to discuss the first quarter 2022 financial results the following morning on Thursday, May 5, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 335781. A live webcast, replay of the call and earnings release, will be availab

      4/13/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care

    Hanger Inc. SEC Filings

    See more
    • SEC Form 15-12G filed by Hanger Inc.

      15-12G - HANGER, INC. (0000722723) (Filer)

      10/13/22 9:00:25 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form EFFECT filed by Hanger Inc.

      EFFECT - HANGER, INC. (0000722723) (Filer)

      10/7/22 12:15:11 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Hanger Inc.

      S-8 POS - HANGER, INC. (0000722723) (Filer)

      10/3/22 1:29:11 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Hanger Inc.

      S-8 POS - HANGER, INC. (0000722723) (Filer)

      10/3/22 1:25:45 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Hanger Inc.

      S-8 POS - HANGER, INC. (0000722723) (Filer)

      10/3/22 1:21:39 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form POS AM filed by Hanger Inc.

      POS AM - HANGER, INC. (0000722723) (Filer)

      10/3/22 1:15:30 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - HANGER, INC. (0000722723) (Filer)

      10/3/22 12:45:29 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

      8-K - HANGER, INC. (0000722723) (Filer)

      9/30/22 4:17:36 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Hanger Inc.

      DEFA14A - HANGER, INC. (0000722723) (Filer)

      9/20/22 8:01:29 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Inc. filed SEC Form 8-K: Other Events

      8-K - HANGER, INC. (0000722723) (Filer)

      9/20/22 8:00:29 AM ET
      $HNGR
      Medical Specialities
      Health Care

    Hanger Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hanger downgraded by Jefferies with a new price target

      Jefferies downgraded Hanger from Buy to Hold and set a new price target of $18.75 from $24.00 previously

      7/25/22 7:27:44 AM ET
      $HNGR
      Medical Specialities
      Health Care